Procept Biorobotics Corporation
A maker of robotic surgery systems, PROCEPT BioRobotics builds the AquaBeam, a device that treats an enlarged prostate by using a robotically guided, heat-free waterjet to precisely remove excess tissue — no lasers or scalpels needed. Founded in 2007 by engineer Nikolai Aljuri and surgeon Rodney Perkins, the company named its therapy Aquablation, blending "aqua" (water) with "ablation" (tissue removal) to describe the water-powered procedure used by urologists.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 13G/APassive | 8.2% | 4.65M | Jul 29, 2026 |
| AllianceBernstein L.P. | 13G/APassive | 0.3% | 147.3K | May 18, 2026 |
| Vanguard Capital Management | 13GPassive | 5% | 2.82M | Apr 30, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |
| FMR LLC | 13G/APassive | 2.9% | 1.61M | Mar 6, 2026 |
| Abigail P. Johnson | 13G/APassive | 2.9% | 1.61M | Mar 6, 2026 |
| T. Rowe Price Investment Management, Inc. | 13GPassive | 5.9% | 3.27M | Feb 17, 2026 |
| BNP Paribas Asset Management Holding S.A. | 13GPassive | 5.5% | 3.09M | Feb 11, 2026 |